The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review)

International Journal of Oncology · Published 2026-07-16 · DOI 10.3892/ijo.2026.5921

Free full text

Authors (6)

Yu Zhao, Chenghai He, Kexin Chen, Nanting Sun, Ruonan He, Guodong Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhao, Y., He, C., Chen, K., et al. (2026). The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2026.5921

Related articles

• PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review) · International Journal of Oncology · 2026 · Same journal
• METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review) · International Journal of Oncology · 2026 · Same journal
• Smoking promotes colorectal cancer via the CKAP2L/AREG axis · International Journal of Oncology · 2026 · Same journal
• [Retracted] Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells · International Journal of Oncology · 2026 · Same journal
• Biomarkers for oesophageal squamous cell carcinoma and the role of HPV: Multi‑omics approaches and current evidence (Review) · International Journal of Oncology · 2026 · Same journal
• Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity · International Journal of Oncology · 2026 · Same journal
• Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review) · International Journal of Oncology · 2026 · Same journal
• Research advances in aptamers in the diagnosis and treatment of breast cancer (Review) · International Journal of Oncology · 2026 · Same journal
• Radiotherapy resistance in glioblastoma: Mechanistic insights and novel therapeutic approaches (Review) · International Journal of Oncology · 2026 · Same journal
• [Retracted] Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase‑2 · International Journal of Oncology · 2026 · Same journal